TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.41 0.0 (1.21%) --- --- 0.0 (-0.19%) --- --- 0.0 (1.21%) 0.0 (1.21%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.2124
Diluted P/E:
-0.2124
RSI(14) 1m:
40.96
VWAP:
0.41
RVol:
0.0114

Events

Period Kind Movement Occurred At
1m Price increase 1m 0.74 +0.01 (+1.15%) Oct 15 16:45
1m Price increase 1m 0.72 +0.04 (+5.35%) Oct 15 16:42
10m Price increase 10m 0.72 +0.04 (+6.45%) Oct 15 16:42
1m Price increase 1m 0.69 +0.01 (+2.06%) Oct 15 16:41
1m Price decrease 1m 0.68 -0.01 (-1.37%) Oct 15 16:39

Related News